Jessica.F

Final Thoughts on Chemistry for 95-11-4

COA of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M or concate me.

COA of Formula: C8H9N. Recently I am researching about LIQUID-PHASE HYDROGENATION; HIGHLY-ACTIVE HYDROGENATION; ORGANIC FRAMEWORK NODES; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; CATALYTIC-HYDROGENATION; COMPLEXES; ISOOCTENES; KINETICS; CO, Saw an article supported by the State of Mecklenburg Western Pomerania, the BMBFFederal Ministry of Education & Research (BMBF) [03XP0060]. Published in ROYAL SOC CHEMISTRY in CAMBRIDGE ,Authors: Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

Catalytic hydrogenation of olefins using noble metal catalysts or pyrophoric RANEY (R) nickel is of high importance in the chemical industry. From the point of view of green and sustainable chemistry, design and development of Earth-abundant, less toxic, and more environmentally friendly catalysts are highly desirable. Herein, we report the convenient preparation of active cobalt catalysts and their application in hydrogenations of a wide range of terminal and internal carbon-carbon double bonds in water under mild conditions. Catalysts are prepared on multi-gram scale by pyrolysis of cobalt acetate and uracil, guanine, adenine or l-tryptophan. The most active material Co-Ura/C-600 showed good productivity in industrially relevant hydrogenation of diisobutene to isooctane and in natural oil hardening.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Our Top Choice Compound:C8H9N

Quality Control of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M or concate me.

Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M in [Pews-Davtyan, Anahit; Scharnagl, Florian Korbinian; Hertrich, Maximilian Franz; Kreyenschulte, Carsten; Bartling, Stephan; Lund, Henrik; Jackstell, Ralf; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29a, D-18059 Rostock, Germany published Biomolecule-derived supported cobalt nanoparticles for hydrogenation of industrial olefins, natural oils and more in water in 2019, Cited 62. Quality Control of 5-Norbornene-2-carbonitrile. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4.

Now Is The Time For You To Know The Truth About C8H9N

About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Wang, ZM; Yang, CX; Yan, XP or concate me.. Category: nitriles-buliding-blocks

Category: nitriles-buliding-blocks. In 2019 J CHROMATOGR A published article about METAL-ORGANIC FRAMEWORKS; ABSOLUTE STRUCTURE DETERMINATION; STATIONARY PHASES; ENANTIOMER SEPARATION; RESOLUTION; RECOGNITION; HPLC; SULFOXIDES; CATALYSIS; ISOMERS in [Wang, Zi-Meng; Yang, Cheng-Xiong] Nankai Univ, Tianjin Key Lab Mol Recognit & Biosensing, Res Ctr Analyt Sci, Coll Chem, Tianjin 300071, Peoples R China; [Yan, Xiu-Ping] Jiangnan Univ, State Key Lab Food Sci & Technol, Int Joint Lab Food Safety, Inst Analyt Food Safety,Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China in 2019, Cited 51. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4.

Chiral crystalline sponges (CCSs) are a recent class of chiral porous metal complexes potential in chiral recognition. Here we report the fabrication of polysiloxane OV-1701 incorporated CCS-3S (PSO/CCS-3S) coated capillary column as a novel stationary phase for gas chromatographic separation of diverse race-mates. CCS-3S with the chiral ligand of (S)-mandelic was selected as the model CCS. With the aid of polysiloxane OV-1701, PSO/CCS-3S coated capillary column gave improved resolution, broader enantiomers separation scope and much larger McReynolds constants than CCS-3S coated capillary column. Many racemates that cannot be separated on CCS-3S coated capillary column were well resolved on PSO/CCS-3S coated capillary column. The PSO/CCS-3S coated capillary column also gave wide linear range, low limit of detection, good repeatability and reproducibility, and fine inertness and anti-column bleeding properties for the separation of enantiomers. In addition, the PSO/CCS-3S coated capillary column presented better resolution for the studied racemates than commercial beta-cyclodextrin based Cyclosil B (30 m long x0.32 mm i.d. x 0.25 mu m film thickness), beta-DEX 225 (30 m long x0.25 mm i.d. x 0.25 mu m film thickness) and amino acid based Chirasil L-Val (25 m long x0.25 mm i.d. x 0.12 mu m film thickness) capillary columns. These results indicate the great potential of PSO/CCS-3S coated capillary column in separation of enantiomers. (C) 2019 Elsevier B.V. All rights reserved.

About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Wang, ZM; Yang, CX; Yan, XP or concate me.. Category: nitriles-buliding-blocks

New explortion of 95-11-4

About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M or concate me.. SDS of cas: 95-11-4

SDS of cas: 95-11-4. In 2019 GREEN CHEM published article about LIQUID-PHASE HYDROGENATION; HIGHLY-ACTIVE HYDROGENATION; ORGANIC FRAMEWORK NODES; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; CATALYTIC-HYDROGENATION; COMPLEXES; ISOOCTENES; KINETICS; CO in [Pews-Davtyan, Anahit; Scharnagl, Florian Korbinian; Hertrich, Maximilian Franz; Kreyenschulte, Carsten; Bartling, Stephan; Lund, Henrik; Jackstell, Ralf; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29a, D-18059 Rostock, Germany in 2019, Cited 62. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4.

New learning discoveries about 95-11-4

About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.. Name: 5-Norbornene-2-carbonitrile

Name: 5-Norbornene-2-carbonitrile. Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.. Name: 5-Norbornene-2-carbonitrile

Why do aromatic interactions matter of compound:5-Norbornene-2-carbonitrile

Authors Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M in ROYAL SOC CHEMISTRY published article about LIQUID-PHASE HYDROGENATION; HIGHLY-ACTIVE HYDROGENATION; ORGANIC FRAMEWORK NODES; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; CATALYTIC-HYDROGENATION; COMPLEXES; ISOOCTENES; KINETICS; CO in [Pews-Davtyan, Anahit; Scharnagl, Florian Korbinian; Hertrich, Maximilian Franz; Kreyenschulte, Carsten; Bartling, Stephan; Lund, Henrik; Jackstell, Ralf; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29a, D-18059 Rostock, Germany in 2019, Cited 62. COA of Formula: C8H9N. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

The Absolute Best Science Experiment for C8H9N

Application In Synthesis of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alnaimat, AS; Barciela-Alonso, MC; Herbello-Hermelo, P; Dominguez-Gonzalez, R; Bermejo-Barrera, P or concate me.

Recently I am researching about CAMELLIA-SINENSIS L.; BLACK TEAS; ICP-MS; BIOAVAILABILITY; INFUSIONS; CALCIUM; METALS; FE; CLASSIFICATION; CONTAMINATION, Saw an article supported by the Xunta de Galicia (Grupo de Referencia Competitiva)Xunta de Galicia [ED431C2018/19]; Conselleria de Educacion Program for the Development of Strategic Grouping in Materials -AEMAT at the University of Santiago de Compostela [ED431E2018/08]; Xunta de GaliciaXunta de GaliciaEuropean Commission; FEDER (EU)European Commission. Published in ELSEVIER in AMSTERDAM ,Authors: Alnaimat, AS; Barciela-Alonso, MC; Herbello-Hermelo, P; Dominguez-Gonzalez, R; Bermejo-Barrera, P. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile. Application In Synthesis of 5-Norbornene-2-carbonitrile

Bioaccessibility of trace elements (Li, Be, Ti, Ga, Cu, Ag, Hg, Cd, Cs, Pt, Tl, Pb, As, Cr, Co, Ni, V, Se, Sn and Sb) and major elements (Rb, Ba, Al, Fe, Zn, Si, Ca, Mg, Mn, Mo, Sr, P and K) in tea infusions has been assessed using an in vitro dialyzability protocol. Gastric simulation (using pepsin solution) and intestinal simulation (using pancreatin and bile salts) were used to perform the in vitro digestion. ICP-MS, ICP-OES and FAES were used for elements determination in digested tea leaves, their infusions and the dialyzate fractions from tea infusions. Microwaves assisted acid digestion was used for the total element determination in tea leaves, while tea infusions were prepared by brewing tea leaves for 5 min in boiling water. The LODs for elements determined in tea leaves were in the range of 0.11-656 ng g(-1) and 0.02-145.6 mu g g(-1) for trace and major elements, respectively. For elements’ determination in tea infusions, the LODs were ranged between 0.23 and 399.9 ng L-1 for trace elements and 0.2-1248 mu g L-1 for major elements. The LODs for the elements in the dialyzable fraction varied from 0.018 to 142 mu g L-1. The accuracy of the total element determination was evaluated using certified reference materials (Tea Leaves INCT-TL-1 and Rye Grass). The analytical recoveries were also assessed for analyzed elements in digested tea leaves (95-114%) and their infusions (92-115%), showing good recoveries. Among the studied elements, K was the most abundant element in tea leaves and tea infusions in almost all samples, followed by Ca, Mg, and P. Zn, Cs, and K showed the highest dialyzability percentages up to 84%, 76%, and 54%, respectively, followed by Si and Ca and K that show moderate to high dialyzability percentages. The accuracy of the dialysis process was evaluated using a mass-balance study.

The Shocking Revelation of 5-Norbornene-2-carbonitrile

HPLC of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M or concate me.

Authors Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M in ROYAL SOC CHEMISTRY published article about LIQUID-PHASE HYDROGENATION; HIGHLY-ACTIVE HYDROGENATION; ORGANIC FRAMEWORK NODES; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; CATALYTIC-HYDROGENATION; COMPLEXES; ISOOCTENES; KINETICS; CO in [Pews-Davtyan, Anahit; Scharnagl, Florian Korbinian; Hertrich, Maximilian Franz; Kreyenschulte, Carsten; Bartling, Stephan; Lund, Henrik; Jackstell, Ralf; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29a, D-18059 Rostock, Germany in 2019, Cited 62. HPLC of Formula: C8H9N. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Brief introduction of 95-11-4

Recommanded Product: 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.

Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. Recommanded Product: 5-Norbornene-2-carbonitrile. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. Recommanded Product: 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.

Simple exploration of 5-Norbornene-2-carbonitrile

Safety of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.

Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S in [Makrilakis, Konstantinos; Ioannidis, Ioannis; Iraklianou, Stella; Raptis, Athanasios; Sotiropoulos, Alexis; Liatis, Stavros] Hellen Diabet Assoc, Athens, Greece; [Makrilakis, Konstantinos; Liatis, Stavros] Natl & Kapodistrian Univ Athens, Med Sch, Dept Propaedeut Internal Med 1, Athens, Greece; [Kalpourtzi, Natasa; Kantzanou, Maria; Touloumi, Giota] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Dept Internal Med 1, Nea Ionia, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Diabet Ctr, Nea Ionia, Greece; [Iraklianou, Stella] Gen Hosp Tzaneio, Dept Internal Med 3, Piraeus, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Med Sch, Attikon Univ Hosp, Dept Propaedeut Internal Med 2,Res Unit, Athens, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Diabet Ctr, Athens, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Internal Med Dept 3, Nikea, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Diabet Ctr, Nikea, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Med Sch, Dept Primary Hlth Care Gen Practice & Hlth Serv R, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Publ Hlth, Patras, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Lab Biostat, Iraklion, Greece; [Trypsianis, Grigoris] Democritus Univ Thrace, Med Sch, Lab Med Stat, Thrace, Greece; [Voulgari, Paraskevi V.] Univ Ioannina, Med Sch, Dept Internal Med, Ioannina, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece published Prevalence of diabetes and pre -diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study in 2021, Cited 43. Safety of 5-Norbornene-2-carbonitrile. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4.

Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre -diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. Safety of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.